This Research Topic is part of the Women in Science series. Other titles in the series are:
Women in Science - Gastroenterology 2023
Women in Science - Hematology 2023
Women in Science - Rheumatology 2023
The proportion of women and men in science, technology, engineering, and mathematics (STEM) at undergraduate levels is relatively equal, however, there is a lack of representation of women in senior positions in Medicine. According to the UNESCO Institute for Statistics (UIS) data in 2016, less than 30% of senior or principal investigators in STEM are women.
In the field of Gene and Cell Therapy, many highly influential and successful women are driving forward the field and tackling important questions. Yet, female scientists are still underrepresented in various aspects of academic life. Several initiatives have recently been pioneered to increase the visibility of women in science (e.g., awards for women in STEM). However, evidence indicates that gender bias is still present throughout many scientific disciplines.
This Research Topic would like to highlight contributions of women in Gene Therapy and Cell Therapy disciplines and will therefore welcome:
• General perspectives on a specific field of research inspired, started, or led by a woman
• Articles celebrating outstanding female researchers and their contributions to the field of Gene and Cell Therapy
• Studies led by women applying technological innovation to solve health problems
To be considered for this collection, the first, last, or corresponding author should be researchers identifying as female. We recommend early career researchers team up with senior female colleagues to highlight the diversity of talent and breadth of expertise.
Keywords:
gene therapy, cell therapy, medicine, UNESCO, STEM, health, biomedical science, stem cells
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
This Research Topic is part of the Women in Science series. Other titles in the series are:
Women in Science - Gastroenterology 2023 Women in Science - Hematology 2023 Women in Science - Rheumatology 2023The proportion of women and men in science, technology, engineering, and mathematics (STEM) at undergraduate levels is relatively equal, however, there is a lack of representation of women in senior positions in Medicine. According to the UNESCO Institute for Statistics (UIS) data in 2016, less than 30% of senior or principal investigators in STEM are women.
In the field of Gene and Cell Therapy, many highly influential and successful women are driving forward the field and tackling important questions. Yet, female scientists are still underrepresented in various aspects of academic life. Several initiatives have recently been pioneered to increase the visibility of women in science (e.g., awards for women in STEM). However, evidence indicates that gender bias is still present throughout many scientific disciplines.
This Research Topic would like to highlight contributions of women in Gene Therapy and Cell Therapy disciplines and will therefore welcome:
• General perspectives on a specific field of research inspired, started, or led by a woman
• Articles celebrating outstanding female researchers and their contributions to the field of Gene and Cell Therapy
• Studies led by women applying technological innovation to solve health problems
To be considered for this collection, the first, last, or corresponding author should be researchers identifying as female. We recommend early career researchers team up with senior female colleagues to highlight the diversity of talent and breadth of expertise.
Keywords:
gene therapy, cell therapy, medicine, UNESCO, STEM, health, biomedical science, stem cells
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.